Design and application of fluorometric assays for human cytochrome P450 inhibition

Methods in Enzymology

Volumn 357, Issue , 2002, Pages 276-284

  Crespi, Charles L ^a   Miller, Vaughn P ^a   Stresser, David M ^a  

^a BD Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DICLOFENAC; DRUG METABOLIZING ENZYME; ETHER DERIVATIVE; FURAFYLLINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NEW DRUG; NIMODIPINE; QUINIDINE; SULFAPHENAZOLE; TRANYLCYPROMINE;

ARTICLE; DRUG METABOLISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; FLUOROMETRY; PRIORITY JOURNAL; VALIDATION PROCESS;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0036028389     PISSN: 00766879     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0076-6879(02)57685-0     Document Type: Article

References (8)

1. S. Rendic and F. J. Di Carlo, Drug Metab. Rev. 29, 413 (1997)
2. C. L. Crespi, V. P. Miller, and B. W. Penman, Anal. Biochem. 248, 188 (1997)
3. R. C. Onderwater, J. Venhorst, J. N. Commandeur, and N. P. Vermeulen, Chem. Res. Toxicol. 12, 555 (1999)
4. A. B. Renwick, D. F. V. Lewis, S. Fulford, D. Surry, B. Williams, P. D. Worboys, B. G. Lake, and D. C. Evans, Xenobiotica 31, 187 (2001)
5. N. Chauret, B. Dobbs, R. L. Lackman, K. Bateman, D. A. Nicoll-Griffith, D. M. Stresser, J. M. Ackermann, S. D. Turner, V. P. Miller, and C. L. Crespi, Drug Metab. Dispos. 29, 1196 (2001)
6. D. M. Stresser, A. P. Blanchard, S. D. Turner, J. C. Erve, A. A. Dandeneau, and C. L. Crespi, Drug Metab. Dispos. 28, 1440 (2000)
7. W. F. Busby, Jr., J. M. Ackermann, and C. L. Crespi, Drug Metab. Dispos. 27, 246 (1999)
8. M. Shou, R. Dai, K. R. Korzekwa, T. A. Baille, and T. H. Rushmore, J. Biol. Chem. 276, 2256 (2001)